Clinical Trial Update: Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia [Phase 2]

View source ↗

Summary

Phase IIa/b clinical trial evaluating the PvCS/Montanide ISA-51 malaria vaccine in adults in Chocó, Colombia. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• PvCS/Montanide ISA-51 malaria vaccine (PvCS vaccine with Montanide ISA-51 adjuvant)

Snippet

Sponsor: Malaria Vaccine and Drug Development Center | Conditions: Plasmodium Vivax Malaria, Plasmodium Vivax Infection | Phase 2 | Status: NOT_YET_RECRUITING